A carregar...
New biomarkers for checkpoint inhibitor therapy
Immune checkpoint inhibitor blockade has vastly changed treatment paradigms and improved outcomes of many solid organ malignancies. The achievements of the last decade have transformed the outcomes of several tumour types, most notably metastatic melanoma. There are, however, still large numbers of...
Na minha lista:
| Publicado no: | ESMO Open |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493090/ https://ncbi.nlm.nih.gov/pubmed/32933940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000597 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|